Condition

Lupus Nephritis

ClinicalTrials.gov condition label

Clinical trials6

Recruiting2

Common interventions2

Lead sponsors shown6

Clinical trials

6 shown

Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE)NCT06350110 · 2024-07-10

RECRUITING

Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)NCT01802034 · 2013-02-01

RECRUITING

Diastolic Dysfunction and Inflammatory Biomarkers in Lupus NephritisNCT07837544 · 2026-09-20

NOT_YET_RECRUITING

Autologous Adoptive T Regulatory Cell Transfer in Autoimmune Diseases.NCT05566977 · 2022-12-01

UNKNOWN

Retrospective Analysis of Renal Prognosis in Patients With Chronic Kidney DiseaseNCT03201406 · 2017-06-20

UNKNOWN

At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic ConditionsNCT01931644 · 2013-07-01

COMPLETED

Common interventions

autologous adoptive T regulatory cell transfer.OTHER1CD19- BCMA CAR-T cellsBIOLOGICAL1

Leading sponsors

Ain Shams University1Assiut University1Essen Biotech1National Taiwan University Hospital1Sanguine Biosciences1The Rogosin Institute1

Trial status mix

RECRUITING2

UNKNOWN2

COMPLETED1

NOT_YET_RECRUITING1

Phase mix

PHASE12

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.